SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

U.S. Stem Cell Inc. (USRM)

Add USRM Price Alert      Hide Sticky   Hide Intro
Moderator: TheHungryHippo, Papa Bear, BluSkies, StaleyCornell, buythebuy, mtlebomac
Search This Board: 
Last Post: 4/24/2017 6:47:27 PM - Followers: 831 - Board type: Free - Posts Today: 172



Bioheart, Inc. is committed to the discovery and development of autologous cellular therapies to treat a variety of degenerative diseases, as well as the continuation of our ongoing research for the treatment of heart failure, cardiovascular and perioheral vascular disease. 


The US. Stem Cell Inc. Vision
Our vision is to improve the quality of patients’ lives, while reducing hospitalizations and healthcare costs. 
Bioheart is and will continue to be recognized by physicians and patients as the world’s leader in providing 
innovative treatment and management of patients with severe cardiovascular and peripheral vascular 
disease.We are also focused on the discovery, development and commercialization of autologous cell therapies 
for the treatment of degenerative diseases.




Mike Tomás

President & CEO

Mike Tomas. Mr. Mike Tomas was appointed President and Chief Executive Officer and a member of our Board of Directors on June 19, 2010. Mike Tomas was appointed as the Company’s President and Chief Executive Officer, and as a director on June 19, 2010. Mr. Tomas has been President for the past nine years of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart since 2001. In 2003, he joined Bioheart’s Board of Directors as the independent representative of The ASTRI Group. ASTRI provides capital, business development and strategic marketing support to emerging private companies. Mr. Tomas will continue to serve as President of The ASTRI Group. Previously from 1983 to 2001, Mr. Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. Upon retiring from MCI and WorldCom, Tomas joined other ex-MCI executives and helped raise $40M in venture capital to form Ineto, an integrated customer communications software solution that was successfully sold in 2001.
Mr. Tomas sits on the boards of Avisena (revenue cycle management company for medical practices), SilverSky (fka Perimeter Internetworking) (SaaS/managed security services provider for medical practices and financial institutions), Rokk3r Labs (a digital and mobile products developer and portfolio), Bioheart (adult stem cell development for heart muscle tissue repair) and is the current chairman of Florida International University’s Global Entrepreneurship Center. He is an inductee into the Miami-Dade College and WACE Halls of Fame for business, an FIU Torch Award winner — and winner of top communications, medical innovations, education and entrepreneurial awards. Mr. Tomas holds a Masters of Business Administration from the University of Miami and a Bachelor’s degree from Florida International University.

Kristin Comella

Chief Scientific Officer

Kristin Comella. Ms. Comella was appointed Chief Scientific Officer in September 2010. Ms. Comella has served as our Vice President of R&D and Corporate Development since December 2008 and has played a major role in managing our product development, manufacturing and quality systems since joining Bioheart in 2004. Ms. Comella has 15 years of industry experience with expertise in regenerative medicine, training and education, research and product development, and currently serves on multiple advisory boards in the stem cell arena. Ms. Comella has many years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy and developing stem cell therapies for osteoarthritis at Osiris Therapeutics. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.  On March 12, 2013, Kristin Comella was appointed to serve as a member of our Board of Directors.

Dr. William P. Murphy, Jr.

William P. Murphy, Jr., M.D. Dr. Murphy has served as a member of our Board of Directors since June 2003. Dr. Murphy founded Small Parts, Inc., a supplier of high quality mechanical components for design engineers, in 1964 and served as its Chairman until his retirement in April 2005. Small Parts, Inc. was acquired by, Inc. in March 2005. From October 1999 until October 2004, Dr. Murphy served as the Chairman and Chief Executive Officer of Hyperion, Inc., a medical diagnosis company which had an involuntary bankruptcy filed against it in December 2003. Dr. Murphy is the founder of Cordis Corporation (now Cordis Johnson & Johnson) which he led as President, Chairman and Chief Executive Officer at various times during his 28 years at Cordis until his retirement in October 1985. Cordis Johnson & Johnson is a leading firm in cardiovascular instrumentation. Dr. Murphy received an M.D. in 1947 from the University of Illinois and a B.S in pre-medicine from Harvard College in 1946. He also studied physiologic instrumentation at Massachusetts Institute of Technology, or MIT. After a two year rotating internship at St. Francis Hospital in Honolulu, he became a Research Fellow in Medicine at the Peter Bent Brigham Hospital in Boston where he was the dialysis engineer on the first clinical dialysis team in the United States. He continued as an Instructor in Medicine and then a research associate in Medicine at Harvard Medical School. Dr. Murphy is the author of numerous papers and owns 17 patents. He is the recipient of a number of honors, including the prestigious Lemelson-MIT Lifetime Achievement Award, the MIT Corporate Leadership Award, the Distinguished Service Award from North American Society of Pacing and Electrophysiology, and the Jay Malina Award from the Beacon Council of Miami, Florida. He is also a member of the Inventors Hall of Fame


Executive Officers and Directors

Set forth below is information regarding our executive officers and directors as of December 31, 2013

Mike Tomas 48 Director, President and Chief Executive Officer, Chief Financial Officer
William P. Murphy, Jr., M.D. 90 Director, Chairman of the Board
Mark P. Borman  59  Director
Charles A. Hart  53 Director
Sam Ahn  59 Director
Kristen Comella  37 Director, Chief Scientific Officer
Sheldon T. Anderson 63 Director


Business Strategy

 Our principal objective is to become a leading regenerative medicine company that discovers, develops and commercializes novel, autologous cell therapies, and related devices, for the treatment and improved care of patients suffering from chronic and acute heart damage as well as lower limb ischemia. Our secondary objective is the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases.  The number of heart failure patients is expected to increase from 25 million worldwide today to over 50 million in five years. Our focus is on serving these patients. To achieve our primary objective, we plan to pursue the following strategies:

  • - Obtain initial regulatory approval of MyoCell and/or MyoCell SDF-1 by targeting patients with severe heart damage. 
    - Continue existing studies with adipose derived stem cells and endothelial progenitor cells.
    - Continue to develop our pipeline of cell-based therapies and related devices for the treatment of chronic and acute heart damage. 
    - Develop our sales and marketing capabilities. 
    - Continue to refine our MyoCell and MyoCell SDF-1 cell culturing processes.
    - Expand and enhance our intellectual property rights.
    - License, acquire and/or develop complementary products and technologies. 

USRM - Daily Candlesticks


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
USRM News: Significant Updates on the Following Companies and New Coverage 04/20/2017 09:00:00 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:49:04 AM
USRM News: Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth 04/12/2017 08:47:59 AM
USRM News: Statement of Changes in Beneficial Ownership (4) 03/31/2017 04:02:24 PM
USRM News: Statement of Changes in Beneficial Ownership (4) 03/17/2017 04:02:15 PM
#52397  Sticky Note This is the guy who is investing up Vita Nova Stocks 04/15/17 09:22:22 AM
#42457  Sticky Note THIS IS A MUST READ slam4202 03/30/17 07:05:37 AM
#42449  Sticky Note CEO BLOG / FDA "On regulatory news, BluSkies 03/30/17 04:51:30 AM
#26891  Sticky Note $USRM ALL IN ONE DD Post for Investors: TheHungryHippo 03/09/17 05:25:50 AM
#26168  Sticky Note Thoughts? BluSkies 03/07/17 09:49:57 PM
#54754   Why wouldnt people be buying here, the 5 TradeUptrendz 04/24/17 06:47:27 PM
#54753   Same bro, been adding 50-100k shares a day! TradeUptrendz 04/24/17 06:46:09 PM
#54752   If your long your long bud, this isnt TradeUptrendz 04/24/17 06:45:13 PM
#54751   $USRM nothing else good out there to buy... BoilerRoom 04/24/17 06:18:18 PM
#54750   Same. Great setup $USRM Cheds 04/24/17 06:17:39 PM
#54749   $USRM ended up buying more today BoilerRoom 04/24/17 06:13:40 PM
#54748   Consolidating perfectly. Like I said before, I believe atpavlovich 04/24/17 06:02:20 PM
#54747   Watch and wait buddy you'll make less money damain22 04/24/17 06:00:11 PM
#54745   I think your bottom is in or maybe cat12 04/24/17 05:50:45 PM
#54743   Slow day, would have sure preferred +3% but kkdman 04/24/17 05:15:31 PM
#54742   Good buy. Good thing you did not listen tothe 04/24/17 04:55:42 PM
#54741   No ones going to sell you shares at MyzStreet 04/24/17 04:23:13 PM
#54740   GOOD OBSERVATION !! power11 04/24/17 04:21:59 PM
#54739   About to get fun again Havoc23 04/24/17 04:20:38 PM
#54738   I put my limit buy in last night emit 04/24/17 04:16:28 PM
#54737   This is a great analyzation. This sat BearDickPunch 04/24/17 04:16:09 PM
#54736   That'd be sweet docprep 04/24/17 04:12:29 PM
#54735   I'm still pretty impressed that these levels are Archery Class 04/24/17 04:08:24 PM
#54734   Wish the news would come after bell to shaman919 04/24/17 03:59:36 PM
#54733   I like the colors makes the wait here 11JR11 04/24/17 03:53:32 PM
#54732   It will come when needed. From everything I MyzStreet 04/24/17 03:53:31 PM
#54731   Every day. Set your clock by it. LOL sdave2002 04/24/17 03:53:20 PM
#54730   LOL, yeah, just like the crying that is sdave2002 04/24/17 03:52:08 PM
#54729   I love watching the different strategies they implement. 11JR11 04/24/17 03:52:03 PM
#54728   I bet that ASK size is as fake sdave2002 04/24/17 03:49:14 PM
#54727   Maybe I will not your F****** bizness , dough11 04/24/17 03:49:12 PM
#54726   Are you going to sell? There are plenty sdave2002 04/24/17 03:46:49 PM
#54725   If they don't get some type of commitment dough11 04/24/17 03:40:04 PM
#54723   Still holding, being patient is boring but I Aces-DeucesMM 04/24/17 03:01:38 PM
#54722   it means that news are coming out soon. Chupacabras 04/24/17 02:58:45 PM
#54720   I hear ya man. I'm still holding, and Chicagojosh 04/24/17 02:47:55 PM
#54717 parrishilton 04/24/17 02:39:51 PM
#54716   It was hugely exciting. I was literally BearDickPunch 04/24/17 02:39:17 PM
#54715   I hope so, been a steady bleed since Chicagojosh 04/24/17 02:31:08 PM
#54714   Chart is fantastic and more days like this Cheds 04/24/17 02:16:10 PM
#54713   agreed, both sides are waiting. sdave2002 04/24/17 02:11:55 PM
#54712   Low volume is very good here $USRM Cheds 04/24/17 02:05:01 PM
#54709   Starter $USRM Cheds 04/24/17 01:45:59 PM
#54708   Shaping up for a much larger cup and dtx180 04/24/17 01:44:45 PM
#54707   Relaxed....Feet up........this stock has gotten so thin over TradeUptrendz 04/24/17 01:43:38 PM
#54706   Great post NoMoDo! MyzStreet 04/24/17 01:39:07 PM
#54705   By the ASK now or by the GAP later damain22 04/24/17 01:34:54 PM
#54704   Got ya. I agree. shaman919 04/24/17 01:33:02 PM
#54703   $USRM breakthrough therapy BoilerRoom 04/24/17 01:33:00 PM
#54701   Take your pick. FDA, 8K on 5 mil sdave2002 04/24/17 01:31:56 PM
#54700   What match shaman919 04/24/17 01:26:47 PM
#54699   Scott Gottlieb to be confirmed on Wednesday. Nice article. elvis618 04/24/17 01:24:59 PM
#54698   Just need that match (news) to light this candle. sdave2002 04/24/17 01:21:58 PM
#54697   Chart looks like a launchpad!! afterhoursearnings 04/24/17 01:00:59 PM
#54696   Snore fest 2017 shaman919 04/24/17 01:00:32 PM